Antibodies against glutaraldehyde-modified albumin in normal mouse sera. 1982

D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea

An antigen-coated plate radioimmunoassay was used to detect antibodies against homologous glutaraldehyde-modified albumin (in monomeric or polymeric form) in normal mouse sera. Mouse antibodies reacted also with heterologous glutaraldehyde-treated albumin; for instance human albumin. Immunoelectrophoresis of purified anti-albumin antibodies and adsorption experiments on protein A-Sepharose 4B gel indicated that mouse antibodies belong mainly to the IgG class. The ability of mouse anti-albumin antibodies to react also with pyridinium compounds suggested that such structures are probably part of the new antigenic determinants induced in mouse albumin by glutaraldehyde treatment. It was assumed that anti-albumin antibodies have a physiologic role in the recognition and removal from the circulation of in vivo 'aged' mouse albumin.

UI MeSH Term Description Entries
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005976 Glutaral One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative. Glutaraldehyde,Cidex,Diswart,Gludesin,Glutardialdehyde,Glutarol,Korsolex,Novaruca,Sekumatic,Sonacide,Sporicidin
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum

Related Publications

D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
January 1983, Immunology letters,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
April 1975, International journal of cancer,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
October 1983, Experientia,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
May 1992, Thrombosis research,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
July 1974, The Journal of clinical investigation,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
January 1955, International archives of allergy and applied immunology,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
August 1987, Journal of neurochemistry,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
May 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
July 1977, Cancer research,
D Onică, and I Mărgineanu, and C Medeşan, and A Călugăru, and M Manciulea
November 1968, Danish medical bulletin,
Copied contents to your clipboard!